Course Description
The International Retinal Imaging Symposium III will take place on Saturday, March 28, 2015 at the Ronald Reagan Medical Center at UCLA and will feature a series of lectures that will focus on the latest developments in retinal imaging, including: adaptive optics, fundus autofluorescence, spectral domain and swept source optical coherence tomography (OCT) and OCT angiography, and ultra-widefield imaging. This conference will include a full day of lectures by many of the world's experts in retinal imaging who will speak on recent innovations in retinal imaging that have occurred in this rapidly advancing field.
Our world-renowned faculty will aim to familiarize course participants with the newest evolving technologies and will guide and instruct our registrants in the application of these advanced systems and in the interpretation of novel imaging findings. This will help our participants better manage their patients with macular and retinal disease and achieve better patient outcomes in their practices.
We welcome your participation at IRIS which promises to provide insight and understanding in retinal imaging and showcase the integral importance of innovative retinal imaging in the evaluation and management of retinal disease.
David Sarraf, M.D.
K. Bailey Freund, M.D.
Registration Information
Early enrollment is advised.
Online
To enroll click here
By Mail
Send the completed enrollment form to:
Office of Continuing Medical Education
David Geffen School of Medicine at UCLA
International Retinal Imaging Symposium 2015 (IRIS III)
10920 Wilshire Blvd., Suite 1060
Los Angeles, CA 90024-6512
By Fax
Fax the enrollment form with charge card information and your authorizing signature to the Office of Continuing Medical Education, David Geffen School of Medicine at UCLA at (310) 794-2624
By Phone
Use your MasterCard, VISA, American Express or Discover. Call (310) 794-2620.
Registration Fees
- $350.00 - MDs
- $150.00 - Residents and Fellows
A handling fee of $75 will be deducted from each cancelled registration.
Faculty
Directors
David Sarraf, M.D.
K. Bailey Freund, M.D.
Co-Directors
Srinivas Sadda, M.D.
Richard Spaide, M.D.
Lawrence Yannuzzi, M.D.
Speakers
Thomas Ach, M.D., Ph.D.
Anita Agarwal, M.D.
Steven Bailey, M.D
Francine Behar-Cohen, M.D., Ph.D.
Suk Ho Byeon, M.D.
Joe Carroll, Ph.D.
Christine Curcio, M.D.
Jay Duker, M.D.
Amani Fawzi, M.D.
K. Bailey Freund, M.D.
James Fujimoto, Ph.D.
Alain Gaudric, M.D.
Tomohiro Iida, M.D., Ph.D.
Yasushi Ikuno, M.D.
Lee Jampol, M.D.
Judy Kim, M.D.
Hideki Koizumi, M.D., Ph.D.
Oh Kwon, M.D.
Brandon J. Lujan, M.D., Ph.D.
Bruno Lumbroso, M.D.
Tara McCannel, M.D., Ph.D.
H. Richard McDonald, M.D.
Edoardo Midena, M.D.
Kyoko Ohno-Matsui, M.D.
Michel Paques, M.D., Ph.D.
Jose Pulido, M.D.
Ehsan Rahimy, M.D.
Giuseppe Querques, M.D.
Richard Rosen, M.D.
Srinivas Sadda, M.D.
David Sarraf, M.D.
Ursula Schmidt-Urfurth, M.D.
Giovanni Staurenghi, M.D.
Alex Walsh, M.D.
David Wilson, M.D.
Lawrence Yannuzzi, M.D.
Moderators
David Boyer, M.D.
Alexander Brucker, M.D.
Michael Gorin, M.D., Ph.D.
Jean-Pierre Hubschman, M.D.
Colin McCannel, M.D.
Carmen Puliafito, M.D.
Steven Schwartz, M.D.
Lawrence Singerman, M.D.
Eric Souied, M.D., Ph.D.
Program Agenda
Saturday, March 28, 2015 |
|
| 7.00 7.40 a.m. | REGISTRATION AND CONTINENTAL BREAKFAST |
| OCT INNOVATIONS MODERATOR: K. Bailey Freund, M.D.. |
|
| 7.40 - 7.50 | Update in SD OCT What's New in 2015 Jay Duker, M.D. |
| 7.50 - 8.00 | The Future of OCT Alex Walsh, M.D. |
| 8.00 - 8.10 | Functional Imaging using Ultrahigh Speed Swept Source OCT James Fujimoto, Ph.D. |
| OCT ANGIOGRAPHY MODERATOR: Carmen Puliafito, M.D. |
|
| 8:20 - 8:30 | Clinical applications of SSADA OCT angiography Bruno Lumbroso, M.D. |
| 8:30 - 8:40 | Game changing findings in AMD using OCT angiography Steven Bailey, M.D. |
| OCT ANATOMY MODERATOR: David Sarraf, M.D. |
|
| 8.50 9.00 | Retinal capillary plexus: normal anatomy David Wilson, M.D. |
| 9.00 910 | Retinal capillary plexus: anatomy and ischemia Ehsan Rahimy, M.D. |
| ADAPTIVE OPTICS MODERATOR: Steven Schwartz, M.D. |
|
| 9:20 9:30 | Complimentary Uses of Adaptive Optics and OCT Imaging Joseph Carroll, Ph.D |
| 9:30 9:40 | Photoreceptor pointing in the retina: combining adaptive optics and OCT Michel Paques, M.D., Ph.D. |
| 9:50 10:00 | Interpretation of the Cone Mosaic with Adaptive Optics Imaging Alain Gaudric, M.D. |
| 10:00 10:10 | Capillary Layer Imaging Using Non-Confocal Split Detection Adaptive Optics Richard Rosen, M.D. |
| 10:20 10:50 | BREAK |
| AUTOFLUORESCENCE MODERATOR: Srinivas Sadda, M.D. |
|
| 10:50 11:00 | Breaking It Down to Individual Cells: The Basis of Fundus Autofluorescence Thomas Ach, M.D., Ph.D. |
| 11:00 11:10 | The RPE Catalogue: A Comprehensive Grading System for RPE Morphology in AMD Christine Curcio, M.D. |
| 11:10 11:20 | RPE Imaging Using Polarization-Sensitive OCT Ursula Schmidt-Erfurth, M.D. |
| DRY AMD MODERATOR: Lawrence Singerman, M.D. |
|
| 11:40 11:50 | Directional OCT analysis of geographic atrophy progression Brandon Lujan, M.D. |
| 11:50 12:00 | New parameters for monitoring progression of geographic atrophy Srinivas Sadda, M.D. |
| 12:00 12:10 | Macular atrophy: an ICGA and Angio-OCT study Giovanni Staurenghi, M.D. |
| WET AMD MODERATOR: Alexander Brucker, M.D. |
|
| 12:20 12:30 | Choroidal imaging in neovascular AMD: New data and clinical significance Hideki Koizumi, M.D., Ph.D. |
| 12:30 12:40 | Multimodal imaging of early type 3 neovascularization: insight into pathogenesis Giuseppe Querques, M.D. |
| 12.40 12.50 | OCT angiography of Type 1 versus Type 3 neovascularization David Sarraf, M.D. |
| 1:00 - 2:00 | LUNCH |
| CSCR MODERATOR: J. P. Hubschman, M.D. |
|
| 2:00 2:10 | EDI-OCT and Fundus Autofluorescence in Central Serous Chorioretinopathy Tomohiro Iida, M.D., Ph.D. |
| 2:10 2:20 | Multimodal Imaging in CSC Francine Behar-Cohen, M.D., Ph.D. |
| 2:20 2:30 | Multimodal Imaging of Pachychoroid Neovasculopathy K. Bailey Freund, M.D. |
| MYOPIA MODERATOR: Colin McCannel, M.D. |
|
| 2:40 2:50 | Wide-field fundus imaging for pathologic myopia Kyoko Ohno-Matsui, M.D. |
| 2:50 - 3:00 | Morphologic characteristics of complications of dome-shaped macula by SS-OCT Yasushi Ikuno, M.D. |
| 3:00 - 3:10 | Image characteristics of Myopic CNV in Korea Oh Kwon, M.D. |
| MACULAR EDEMA MODERATOR: David Boyer, M.D. |
|
| 3:20 - 3:30 | Understanding the Pathoanatomy of Macular Edema with SD-OCT Suk Ho Byeon, M.D. |
| 3:30 - 3:40 | Predicting Visual Outcome in CME Using En Face OCT Amani Fawzi, M.D. |
| 3:40 - 3:50 | Diabetic Macular Edema: Imaging-Driven Treatment Edoardo Midena, M.D. |
| 4:00 - 4:30 | Break |
| INFLAMMATORY MODERATOR: Lawrence Yannuzzi, M.D. |
|
| 4:30 - 4:40 | Multimodal Imaging of Inflammatory Chorioretinopathies Lee Jampol, M.D. |
| 4:40 - 4:50 | Multimodal Imaging of Multifocal Choroiditis Lawrence Yannuzzi, M.D. |
| MISCELLANEOUS MODERATOR: Michael Gorin, M.D., Ph.D. |
|
| 5:00 5:10 | New Imaging Observations in Retinal Dystrophies Anita Agarwal, M.D. |
| 5:10 5:20 | Foveal contour changes in idiopathic epiretinal membrane Judy Kim, M.D. |
| 5:20-5:30 | OCT findings in eyes with unexplained vision loss following vitrectomy H. Richard McDonald, M.D. |
| TUMORS MODERATOR: Lee Jampol, M.D. |
|
| 5:40 5:50 | Advanced intraocular tumor imaging Jose Pulido, M.D. |
| 5:50 - 6:00 | EDI OCT of the choroid post plaque therapy for choroidal melanoma Tara McCannel, M.D., Ph.D. |
Objectives
Accreditation
The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA designates this live activity for a maximum of 8.25 AMA PRA Category 1 Credits TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Disclosures
The FDA has issued a concept paper which classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is "truly independent" and free of commercial influence. In addition to independence, the FDA requires that nonpromotional, commercially supported education be objective, balanced, and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program's participants. In addition, Accreditation Council for Continuing Medical Education policy now mandates that the provider adequately manages all identified potential conflicts of interest prior to the program. We at UCLA fully endorse the letter and spirit of these concepts.